학술논문
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN
Document Type
Article
Author
Silbermann, R.; Laubach, J.; Richardson, P.G.; Kaufman, J.L.; Sborov, D.W.; Reeves, B.; Rodriguez, C.; Chari, A.; Costa, L.J.; Anderson, L.D.; Nathwani, N.; Shah, N.; Bumma, N.; Holstein, S.A.; Costello, C.; Jakubowiak, A.; Orlowski, R.Z.; Shain, K.H.; Cowan, A.J.; Gries, K.S.; Pei, H.; Cortoos, A.; Patel, S.; Lin, T.S.; Voorhees, P.M.; Usmani, S.Z.
Source
In: American Journal of Hematology . (American Journal of Hematology, July 2024, 99(7):1257-1268)
Subject
Language
English
ISSN
10968652
03618609
03618609